220 related articles for article (PubMed ID: 27941538)
1. NF1 and Neurofibromin: Emerging Players in the Genetic Landscape of Desmoplastic Melanoma.
Mahalingam M
Adv Anat Pathol; 2017 Jan; 24(1):1-14. PubMed ID: 27941538
[TBL] [Abstract][Full Text] [Related]
2. The NF1 gene in tumor syndromes and melanoma.
Kiuru M; Busam KJ
Lab Invest; 2017 Feb; 97(2):146-157. PubMed ID: 28067895
[TBL] [Abstract][Full Text] [Related]
3. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
4. Multiple roles of NF1 in the melanocyte lineage.
Larribère L; Utikal J
Pigment Cell Melanoma Res; 2016 Jul; 29(4):417-25. PubMed ID: 27155159
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines.
Andersen LB; Fountain JW; Gutmann DH; Tarlé SA; Glover TW; Dracopoli NC; Housman DE; Collins FS
Nat Genet; 1993 Feb; 3(2):118-21. PubMed ID: 8499944
[TBL] [Abstract][Full Text] [Related]
6. Status of the NF1 tumor suppressor locus in uveal melanoma.
Foster WJ; Fuller CE; Perry A; Harbour JW
Arch Ophthalmol; 2003 Sep; 121(9):1311-5. PubMed ID: 12963615
[TBL] [Abstract][Full Text] [Related]
7. Elucidating distinct roles for NF1 in melanomagenesis.
Maertens O; Johnson B; Hollstein P; Frederick DT; Cooper ZA; Messiaen L; Bronson RT; McMahon M; Granter S; Flaherty K; Wargo JA; Marais R; Cichowski K
Cancer Discov; 2013 Mar; 3(3):338-49. PubMed ID: 23171796
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis type 1 (NF1) gene: Beyond café au lait spots and dermal neurofibromas.
Peltonen S; Kallionpää RA; Peltonen J
Exp Dermatol; 2017 Jul; 26(7):645-648. PubMed ID: 27622733
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver?
Kadokura A; Frydenlund N; Leone DA; Yang S; Hoang MP; Deng A; Hernandez-Perez M; Biswas A; Singh R; Yaar R; Mahalingam M
Hum Pathol; 2016 Jul; 53():82-90. PubMed ID: 26980030
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras.
Johnson MR; Look AT; DeClue JE; Valentine MB; Lowy DR
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5539-43. PubMed ID: 8516298
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors.
Ki DH; He S; Rodig S; Look AT
Oncogene; 2017 Feb; 36(8):1058-1068. PubMed ID: 27477693
[TBL] [Abstract][Full Text] [Related]
12. Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasia.
Sakamoto A; Oda Y; Oshiro Y; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2001 Nov; 32(11):1245-51. PubMed ID: 11727265
[TBL] [Abstract][Full Text] [Related]
13. [Pathogenic alterations within the neurofibromin gene in various cancers].
Nagy Á; Garzuly F; Kálmán B
Magy Onkol; 2017 Dec; 61(4):327-336. PubMed ID: 29257151
[TBL] [Abstract][Full Text] [Related]
14. Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.
Shin J; Padmanabhan A; de Groh ED; Lee JS; Haidar S; Dahlberg S; Guo F; He S; Wolman MA; Granato M; Lawson ND; Wolfe SA; Kim SH; Solnica-Krezel L; Kanki JP; Ligon KL; Epstein JA; Look AT
Dis Model Mech; 2012 Nov; 5(6):881-94. PubMed ID: 22773753
[TBL] [Abstract][Full Text] [Related]
15. NF1 Mutations Are Common in Desmoplastic Melanoma.
Wiesner T; Kiuru M; Scott SN; Arcila M; Halpern AC; Hollmann T; Berger MF; Busam KJ
Am J Surg Pathol; 2015 Oct; 39(10):1357-62. PubMed ID: 26076063
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity.
Tong J; Hannan F; Zhu Y; Bernards A; Zhong Y
Nat Neurosci; 2002 Feb; 5(2):95-6. PubMed ID: 11788835
[TBL] [Abstract][Full Text] [Related]
17. Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.
Dilworth JT; Kraniak JM; Wojtkowiak JW; Gibbs RA; Borch RF; Tainsky MA; Reiners JJ; Mattingly RR
Biochem Pharmacol; 2006 Nov; 72(11):1485-92. PubMed ID: 16797490
[TBL] [Abstract][Full Text] [Related]
18. The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice.
Ismat FA; Xu J; Lu MM; Epstein JA
J Clin Invest; 2006 Sep; 116(9):2378-84. PubMed ID: 16906226
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
20. NF1 Mutations Prevalent but Not Clinically Relevant.
Cancer Discov; 2015 Oct; 5(10):OF1. PubMed ID: 26283687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
